Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Bedossa

Showing results (191-200 of 267) with videos related to

Pageof 27
Sort By:
Bulletin Du Cancer|January 13, 2004
[Clinical practice guidelines: Standards, Options and Recommendations for the diagnosis of carcinomas of unknown primary site]Thierry Lesimple, Jean-Jacques Voigt, Anne Bataillard, et al.
Oncogene|December 22, 2018
Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndromeSamira Laouirem, Aurélie Sannier, Emma Norkowski, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypassMeriem Abdennour, Sophie Reggio, Gilles Le Naour, et al.
Journal of Medical Virology|July 24, 2009
Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4Hesham El Makhzangy, Gamal Esmat, Mohamed Said, et al.
Journal of Hepatology|March 30, 2010
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosisAna-Carolina Cardoso, Rami Moucari, Claudio Figueiredo-Mendes, et al.
Obesity (Silver Spring, Md.)|September 24, 2024
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screenAnu Sharma, Eddison Godina Leiva, Srilaxmi Kalavalapalli, et al.
Gastroenterology|July 3, 2008
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis CSarah Maylin, Michelle Martinot-Peignoux, Rami Moucari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 23, 2011
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis CAna-Carolina Cardoso, Roberto J Carvalho-Filho, Christiane Stern, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2019
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary CholangitisChristopher L Bowlus, Paul J Pockros, Andreas E Kremer, et al.
Bulletin Du Cancer|November 21, 2002
[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site]Roland Bugat, Anne Bataillard, Thierry Lesimple, et al.
Pageof 27

Showing results (191-200 of 267) with videos related to

Sort By:
Pageof 27
Bulletin Du Cancer|January 13, 2004
[Clinical practice guidelines: Standards, Options and Recommendations for the diagnosis of carcinomas of unknown primary site]Thierry Lesimple, Jean-Jacques Voigt, Anne Bataillard, et al.
Oncogene|December 22, 2018
Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndromeSamira Laouirem, Aurélie Sannier, Emma Norkowski, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypassMeriem Abdennour, Sophie Reggio, Gilles Le Naour, et al.
Journal of Medical Virology|July 24, 2009
Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4Hesham El Makhzangy, Gamal Esmat, Mohamed Said, et al.
Journal of Hepatology|March 30, 2010
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosisAna-Carolina Cardoso, Rami Moucari, Claudio Figueiredo-Mendes, et al.
Obesity (Silver Spring, Md.)|September 24, 2024
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screenAnu Sharma, Eddison Godina Leiva, Srilaxmi Kalavalapalli, et al.
Gastroenterology|July 3, 2008
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis CSarah Maylin, Michelle Martinot-Peignoux, Rami Moucari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 23, 2011
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis CAna-Carolina Cardoso, Roberto J Carvalho-Filho, Christiane Stern, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 14, 2019
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary CholangitisChristopher L Bowlus, Paul J Pockros, Andreas E Kremer, et al.
Bulletin Du Cancer|November 21, 2002
[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site]Roland Bugat, Anne Bataillard, Thierry Lesimple, et al.
Pageof 27